GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Price-to-Funds-From-Operations

Benevolent AI (Benevolent AI) Price-to-Funds-From-Operations : (As of Jun. 10, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Benevolent AI (Benevolent AI) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.